Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
Description
This grant opportunity seeks applications for exploratory projects aimed at tackling "undruggable" target classes in human diseases. Researchers should identify a disease-relevant target class that is currently difficult to treat and develop new methods or agents that selectively target these areas. The goal is to encourage innovative strategies to address these challenging targets, advancing the development of selective treatments for them.
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes within intractable human disease. Applicants will identify a human disease relevant undruggable target class and develop a method …
Source
Grant ID
PAR-25-442
Agency
Department of Health and Human Services
Subcategory/Subagency
National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- City or township governments
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Public and State controlled institutions of higher education
- Special district governments
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- State governments
- Native American tribal governments (Federally recognized)
- County governments
- For profit organizations other than small businesses
- Independent school districts
- Small businesses
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Awards & Funding
Total Funding
$1M
Funding Amount
Discretionary
Links
Documents
Similar opportunities
- Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
- Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives
National Institutes of Health
- Exploratory Research for Technology Development
National Institutes of Health
- Notice of Funding Opportunity for Pilot Projects on Understudied Proteins in Rare Diseases
National Institutes of Health
- DoD Rare Cancers, Idea Development Award
Department of Defense